Showing results (161-170 of 715) with videos related to

Sort By:
Pageof 72
International Journal of Hematology|September 4, 2009
Cytogenetic abnormalities in essential thrombocythemia at presentation and transformationMatjaz Sever, Hagop Kantarjian, Sherry Pierce, et al.
Blood|November 15, 2013
Crenolanib is a potent inhibitor of FLT3 with activity against resistance-conferring point mutantsAllison Galanis, Hayley Ma, Trivikram Rajkhowa, et al.
Cancer|March 15, 2008
Molecular basis explanation for imatinib resistance of BCR-ABL due to T315I and P-loop mutations from molecular dynamics simulationsTai-Sung Lee, Steven J Potts, Hagop Kantarjian, et al.
Revista Brasileira De Hematologia E Hemoterapia|October 11, 2012
The significance of major and stable molecular responses in chronic myeloid leukemia in the tyrosine kinase inhibitor eraIlana Zalcberg Renault, Vanesa Scholl, Rocio Hassan, et al.
Cancer Causes & Control : CCC|May 26, 2026
Multilevel insights into obesity, race/ethnicity, and survival in early-onset colorectal cancer in GeorgiaMeng-Han Tsai, Marlo Vernon, Malcolm Bevel, et al.
Blood|May 31, 2011
Comparison of thalidomide and lenalidomide as therapy for myelofibrosisElias Jabbour, Deborah Thomas, Hagop Kantarjian, et al.
Cancer|October 6, 2010
Experimental therapeutics for patients with myeloproliferative neoplasiasMeetu Agrawal, Ravin J Garg, Jorge Cortes, et al.
Cancer|January 16, 2007
Activity of decitabine, a hypomethylating agent, in chronic myelomonocytic leukemiaAhmed Aribi, Gautam Borthakur, Farhad Ravandi, et al.
Blood|July 5, 2003
Effect of circulating blasts at time of complete remission on subsequent relapse-free survival time in newly diagnosed AMLElihu H Estey, Peter F Thall, Xuemei Wang, et al.
Wiley Interdisciplinary Reviews. Systems Biology and Medicine|September 14, 2010
Systems approaches and algorithms for discovery of combinatorial therapiesJacob D Feala, Jorge Cortes, Phillip M Duxbury, et al.
Pageof 72